Table 1.

Expression of AC133 Antigen and CD34 on ALL and AML

Leukemia AC133 CD34
 1. T-ALL  Dim  
 2. T-ALL  —  +  
 3. C-ALL  —  
 4. C-ALL  —  +  
 5. C-ALL  Dim  
 6. C-ALL  Bright  −  
 7. C-ALL  —  − 
 8. C-ALL  Dim  +  
 9. Pro-B ALL  Bright  
10. AML M1/M2  —  −  
11. AML M1/M2  —  
12. AML M1/M2  Dim  +  
13. AML M1/M2  Bright  
14. AML M1/M2  Dim  +  
15. AML M1/M2  Dim  
16. AML M1/M2  Bright  +  
17. AML M1/M2  Dim  
18. AML M1/M2  Bright  +  
19. AML M1/M2  Bright  
20. AML M1/M2  Dim  +  
21. AML M1/M2  Dim  
22. AML M4/M5  Dim  +  
23. AML M4/M5  Dim  
24. AML M4/M5  Dim  +  
25. AML M4/M5  Dim  
26. AML M4/M5  —  +  
27. AML M4/M5  Bright  
28. AML M4/M5  Dim  −  
29. AML M4/M5  Dim  − 
30. AML M4/M5  Dim  +  
31. AML M4/M5  Dim  − 
32. AML M4/M5  Bright  − 
Leukemia AC133 CD34
 1. T-ALL  Dim  
 2. T-ALL  —  +  
 3. C-ALL  —  
 4. C-ALL  —  +  
 5. C-ALL  Dim  
 6. C-ALL  Bright  −  
 7. C-ALL  —  − 
 8. C-ALL  Dim  +  
 9. Pro-B ALL  Bright  
10. AML M1/M2  —  −  
11. AML M1/M2  —  
12. AML M1/M2  Dim  +  
13. AML M1/M2  Bright  
14. AML M1/M2  Dim  +  
15. AML M1/M2  Dim  
16. AML M1/M2  Bright  +  
17. AML M1/M2  Dim  
18. AML M1/M2  Bright  +  
19. AML M1/M2  Bright  
20. AML M1/M2  Dim  +  
21. AML M1/M2  Dim  
22. AML M4/M5  Dim  +  
23. AML M4/M5  Dim  
24. AML M4/M5  Dim  +  
25. AML M4/M5  Dim  
26. AML M4/M5  —  +  
27. AML M4/M5  Bright  
28. AML M4/M5  Dim  −  
29. AML M4/M5  Dim  − 
30. AML M4/M5  Dim  +  
31. AML M4/M5  Dim  − 
32. AML M4/M5  Bright  − 

Bone marrow samples obtained after informed consent from patients with acute leukemia were stained with anti-CD34-FITC and AC133-PE and were analyzed by multiparameter flow cytometry. Leukemic blasts expressing AC133 antigen were subdivided into AC133dim (log fluorescence intensity between the first and the second decade) and AC133bright cells (log fluorescence intensity between the second and the third decade).

Close Modal

or Create an Account

Close Modal
Close Modal